当前位置:首页 / 套细胞淋巴瘤21例临床分析
论著 | 更新时间:2015-11-30
|
套细胞淋巴瘤21例临床分析
Clinical analysis of 21 mantle cell lymphoma patients

内科 201305期 页码:469-470

作者机构:广西柳州市人民医院血液科,柳州市545006

基金信息:(收稿日期:2013-07-05修回日期:2013-09-20)

  • 中文简介
  • 英文简介
  • 参考文献
目的探讨套细胞淋巴瘤(MCL)的临床特点,并对合并骨髓侵犯患者临床资料进行分析。方法回顾性分析我院21例套细胞淋巴瘤的临床特点,比较有骨髓侵犯者的发病年龄、乳酸脱氢酶(LDH)、β2-微球蛋白、白细胞数及生存时间与无骨髓侵犯者有无差异。结果21例患者中男15例,女6例,中位年龄55岁,Ⅲ~Ⅳ期者17例,其中有骨髓侵犯者10例。有骨髓侵犯者的发病年龄、LDH、β2-微球蛋白、白细胞数等指标与无骨髓侵犯者比较均无统计学差异(P均>0.05)。总体生存时间,两者分别为(23.4±4.2)月和(72.6±15.4)月,差异有统计学意义(P=0.035)。结论MCL有骨髓侵犯患者生存期短。
ObjectiveTo investigate the clinical features of mantle cell lymphoma(MCL) and analyse the clinical data of MCL patients with bone marrow involvement. MethodsThe clinical features of 21 patients with MCL in our hospital were retrospectively analyzed. Age of onset,LDH,β2 microglobulin,leukocytes and overall survival time of patients with or without bone marrow involvement were compared. ResultsOf the 23 patients,there were 15 males and 6 females,including 17 cases at clinical stage Ⅲ-Ⅳ and 10 cases with bone marrow involvement.The median age was 55 years. There was no significant difference in age of onset,LDH,β2 microglobulin, leukocytes and other parameters (P>0.05). The overall survival time of them were (23.4±4.2) and (72.6±15.4) months respectively,showing a significant difference(P=0.035). ConclusionMCL patients with bone marrow involvement have a shorter survival time.
  • ref

2127

浏览量

1146

下载量

0

CSCD

工具集